Entrada Therapeutics (TRDA) 10% Owner Kush Parmar Sells Shares

What Happened
Kush M. Parmar (identified as a 10% owner) sold a total of 116,474 Entrada Therapeutics (TRDA) shares in two open-market transactions. On July 30, 2026 he sold 114,756 shares at a weighted average price of $6.93 for proceeds of $795,259. On July 31, 2026 he sold 1,718 shares at $6.85 for proceeds of $11,768. Total proceeds across both sales were about $807,000. These were outright sales (code “S”).

Key Details

• Transaction dates and prices:
  • 2026-07-30: 114,756 shares sold, W.A. price reported $6.93 (range reported $6.75–$6.95). (Footnote F1)
  • 2026-07-31: 1,718 shares sold at $6.85.
• Total shares sold: 116,474; total proceeds ≈ $807,027.
• Shares held/ownership notes:
  • Footnote F2/F3: Some shares are held by 5AM Ventures V, L.P. and 5AM Opportunities I, L.P.; Dr. Parmar is a managing member of the general partners and may be deemed to share voting/investment power. He disclaims beneficial ownership except to the extent of his pecuniary interest in those funds.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Filing timing: Form filed Aug 3, 2026 for trades on Jul 30–31, 2026 (the filing date is a few days after the trades).

Context

• These were sales (not purchases or option exercises). Sales can be routine (portfolio or fund rebalancing) and do not by themselves indicate company prospects.
• Because the holdings and sales involve entities (venture funds) where Dr. Parmar is a managing member, these transactions reflect institutional/fund-level interests rather than necessarily a purely personal trade.
• Footnote F1 offers a more detailed per-price breakdown on request (weighted average covers multiple execution prices).